Repositorio Dspace

Diabetes-specific enteral nutrition formula in hyperglycemic, mechanically ventilated, critically ill patients: a prospective, open-label, blind-randomized, multicenter study

Mostrar el registro sencillo del ítem

dc.contributor.author Mesejo, Alfonso
dc.contributor.author Carlos-Montejo-González, Juan
dc.contributor.author Vaquerizo-Alonso, Clara
dc.contributor.author Lobo-Tamer, Gabriela
dc.contributor.author Zabarte-Martínez, Mercedes
dc.contributor.author Ignacio-Herrero-Meseguer, José
dc.contributor.author Acosta-Escribano, José
dc.contributor.author Blesa-Malpica, Antonio
dc.contributor.author Martínez-Lozano-Aranaga, Fátima
dc.date.accessioned 2026-10-21T06:14:05Z
dc.date.available 2026-10-21T06:14:05Z
dc.date.issued 2015-12
dc.identifier.citation Mesejo A, Montejo-González JC, Vaquerizo-Alonso C, Lobo-Tamer G, Zabarte-Martinez M, Herrero-Meseguer JI, et al. Diabetes-specific enteral nutrition formula in hyperglycemic, mechanically ventilated, critically ill patients: a prospective, open-label, blind-randomized, multicenter study. Crit Care. diciembre de 2015;19(1):390. doi:10.1186/s13054-015-1108-1
dc.identifier.issn 1364-8535
dc.identifier.uri https://sms.carm.es/ricsmur/handle/123456789/28794
dc.description.abstract INTRODUCTION: Although standard enteral nutrition is universally accepted, the use of disease-specific formulas for hyperglycemic patients is still controversial. This study examines whether a high-protein diabetes-specific formula reduces insulin needs, improves glycemic control and reduces ICU-acquired infection in critically ill, hyperglycemic patients on mechanical ventilation (MV). METHODS: This was a prospective, open-label, randomized (web-based, blinded) study conducted at nine Spanish ICUs. The patient groups established according to the high-protein formula received were: group A, new-generation diabetes-specific formula; group B, standard control formula; group C, control diabetes-specific formula. Inclusion criteria were: expected enteral nutrition ?5 days, MV, baseline glucose >126 mg/dL on admission or >200 mg/dL in the first 48 h. Exclusion criteria were: APACHE II ?10, insulin-dependent diabetes, renal or hepatic failure, treatment with corticosteroids, immunosuppressants or lipid-lowering drugs and body mass index ?40 kg/m(2). The targeted glucose level was 110-150 mg/dL. Glycemic variability was calculated as the standard deviation, glycemic lability index and coefficient of variation. Acquired infections were recorded using published consensus criteria for critically ill patients. Data analysis was on an intention-to-treat basis. RESULTS: Over a 2-year period, 157 patients were consecutively enrolled (A 52, B 53 and C 52). Compared with the standard control formula, the new formula gave rise to lower insulin requirement (19.1 ± 13.1 vs. 23.7 ± 40.1 IU/day, p <0.05), plasma glucose (138.6 ± 39.1 vs. 146.1 ± 49.9 mg/dL, p <0.01) and capillary blood glucose (146.1 ± 45.8 vs. 155.3 ± 63.6 mg/dL, p <0.001). Compared with the control diabetes-specific formula, only capillary glucose levels were significantly reduced (146.1 ± 45.8 vs. 150.1 ± 41.9, p <0.01). Both specific formulas reduced capillary glucose on ICU day 1 (p <0.01), glucose variability in the first week (p <0.05), and incidences of ventilator-associated tracheobronchitis (p <0.01) or pneumonia (p <0.05) compared with the standard formula. No effects of the nutrition formula were produced on hospital stay or mortality. CONCLUSIONS: In these high-risk ICU patients, both diabetes-specific formulas lowered insulin requirements, improved glycemic control and reduced the risk of acquired infections relative to the standard formula. Compared with the control-specific formula, the new-generation formula also improved capillary glycemia. TRIAL REGISTRATION: Clinicaltrials.gov NCT1233726 .
dc.language.iso eng
dc.rights Atribución/Reconocimiento 4.0 Internacional
dc.rights.uri https://creativecommons.org/licenses/by/4.0/deed.es *
dc.subject.mesh Adult
dc.subject.mesh Aged
dc.subject.mesh Blood Glucose/analysis/drug effects
dc.subject.mesh Critical Illness/nursing/therapy
dc.subject.mesh Diabetes Mellitus/diet therapy/drug therapy
dc.subject.mesh Enteral Nutrition/methods/nursing
dc.subject.mesh Female
dc.subject.mesh Glycemic Index/drug effects
dc.subject.mesh Humans
dc.subject.mesh Hyperglycemia/drug therapy
dc.subject.mesh Insulin/administration & dosage/therapeutic use
dc.subject.mesh Intensive Care Units
dc.subject.mesh Male
dc.subject.mesh Middle Aged
dc.subject.mesh Nutritional Status/drug effects
dc.subject.mesh Prospective Studies
dc.title Diabetes-specific enteral nutrition formula in hyperglycemic, mechanically ventilated, critically ill patients: a prospective, open-label, blind-randomized, multicenter study
dc.type info:eu-repo/semantics/article 
dc.identifier.pmid 26549276
dc.relation.publisherversion https://ccforum.biomedcentral.com/articles/10.1186/s13054-015-1108-1
dc.type.version info:eu-repo/semantics/publishedVersion
dc.identifier.doi 10.1186/s13054-015-1108-1
dc.journal.title Critical Care
dc.identifier.essn 1466-609X


Ficheros en el ítem

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Atribución/Reconocimiento 4.0 Internacional Excepto si se señala otra cosa, la licencia del ítem se describe como Atribución/Reconocimiento 4.0 Internacional

Buscar en DSpace


Búsqueda avanzada

Listar

Mi cuenta